Raia Drogasil Ownership

RADL3 Stock  BRL 24.04  0.49  2.00%   
Raia Drogasil owns a total of 1.65 Billion outstanding shares. Raia Drogasil has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as Raia Drogasil in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Raia Drogasil, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Raia Drogasil SA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Raia Stock Ownership Analysis

About 27.0% of the company outstanding shares are owned by corporate insiders. The company has Price/Earnings To Growth (PEG) ratio of 2.42. Raia Drogasil SA last dividend was issued on the 8th of December 2022. The entity had 25:26 split on the 22nd of May 2023. Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. The company was founded in 1905 and is headquartered in So Paulo, Brazil. RAIADROGASILON operates under Pharmaceutical Retailers classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 50320 people. To find out more about Raia Drogasil SA contact Marclio Pousada at 55 11 3769 5678 or learn more at https://www.rd.com.br.

Raia Drogasil Outstanding Bonds

Raia Drogasil issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Raia Drogasil SA uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Raia bonds can be classified according to their maturity, which is the date when Raia Drogasil SA has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Raia Stock Analysis

When running Raia Drogasil's price analysis, check to measure Raia Drogasil's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Raia Drogasil is operating at the current time. Most of Raia Drogasil's value examination focuses on studying past and present price action to predict the probability of Raia Drogasil's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Raia Drogasil's price. Additionally, you may evaluate how the addition of Raia Drogasil to your portfolios can decrease your overall portfolio volatility.